glp 1 compounding fda GLP-1 Medications – Guidance and Compounded Products Novo asks FDA to prevent

Exenatide Exenatide (Byetta), an incretin mimetic, is FDA approved for use as adjunctive therapy in patients whose T2DM is inadequately controlled with metformin, an SU, a TZD, or with combination of metformin plus an SU or TZD

Will it make me lose a lot of weight

Additionally, polyphenol-rich foods such as berries, green tea, dark chocolate (70% cocoa or higher), and turmeric may have beneficial effects on metabolic health, though more research is needed to confirm their specific impact on GLP-1 function and optimal consumption amounts

A meta-analysis published in JAMA Network Open (2022) covering 49 RCTs found berberine reduced LDL by a mean 0.54 mmol/L (approximately 21 mg/dL) vs